1. Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine. Issue 15 (8th April 2021) Authors: Hamidi, Ahd; Hoeksema, Femke; Velthof, Pim; Lemckert, Angelique; Gillissen, Gert; Luitjens, Alfred; Bines, Julie E.; Pullagurla, Swathi R.; Kumar, Prashant; Volkin, David B.; Joshi, Sangeeta B.; Havenga, Menzo; Bakker, Wilfried A.M.; Yallop, Christopher Journal: Vaccine Issue: Volume 39:Issue 15(2021) Page Start: 2048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of inactivated poliovirus vaccine from Sabin strains: A progress report. Issue 6 (November 2016) Authors: Okayasu, Hiromasa; Sein, Carolyn; Hamidi, Ahd; Bakker, Wilfried A.M.; Sutter, Roland W. Journal: Biologicals Issue: Volume 44:Issue 6(2016:Nov.) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries. Issue 7 (3rd July 2021) Authors: Kumar, Prashant; Shukla, Ravi S.; Patel, Ashaben; Pullagurla, Swathi R.; Bird, Christopher; Ogun, Oluwadara; Kumru, Ozan S.; Hamidi, Ahd; Hoeksema, Femke; Yallop, Christopher; Bines, Julie E.; Joshi, Sangeeta B.; Volkin, David B. Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 7(2021) Page Start: 2298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples. Issue 48 (27th November 2015) Authors: van der Put, Robert M.F.; de Haan, Alex; van den IJssel, Jan G.M.; Hamidi, Ahd; Beurret, Michel Journal: Vaccine Issue: Volume 33:Issue 48(2015) Page Start: 6908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains. (November 2012) Authors: Hamidi, Ahd; Bakker, Wilfried AM Journal: Pharmaceutical patent analyst Issue: Volume 1:Number 5(2013) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains. (November 2012) Authors: Hamidi, Ahd; Bakker, Wilfried AM Journal: Pharmaceutical patent analyst Issue: Volume 1:Number 5(2013) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modeling the long-term 2-8 °C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated stability data. (January 2022) Authors: Pullagurla, Swathi R.; Kumar, Prashant; Ogun, Oluwadara; Kumru, Ozan S.; Hamidi, Ahd; Hoeksema, Femke; Yallop, Christopher; Bines, Julie E.; Volkin, David B.; Joshi, Sangeeta B. Journal: Biologicals Issue: Volume 75(2022) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Process development of a New Haemophilus influenzae type b conjugate vaccine and the use of mathematical modeling to identify process optimization possibilities. (29th February 2016) Authors: Hamidi, Ahd; Kreeftenberg, Hans; v.d. Pol, Leo; Ghimire, Saroj; v.d. Wielen, Luuk A.M.; Ottens, Marcel Journal: Biotechnology progress Issue: Volume 32:Number 3(2016:May/Jun.) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗